Theravance Biopharma Inc
Company Profile
Business description
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Contact
Ugland House, South Church Street
George Town, PO Box 309
Grand Cayman KY1-1104
CYMT: +1 650 808-6000
E: investor.relations@theravance.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
99
Stocks News & Analysis
stocks
The surprising ASX listed foodie trading nearly half its fair value
stocks
2 cheap ASX stocks that might interest contrarians
stocks
5 red flags that may suggest a company in decline
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,456.80 | 39.80 | 0.47% |
| CAC 40 | 7,615.41 | 170.51 | 2.29% |
| DAX 40 | 19,002.38 | 290.89 | 1.55% |
| Dow JONES (US) | 42,025.19 | 522.09 | 1.26% |
| FTSE 100 | 8,328.72 | 75.04 | 0.91% |
| HKSE | 18,067.07 | 53.91 | 0.30% |
| NASDAQ | 18,013.98 | 440.68 | 2.51% |
| Nikkei 225 | 37,893.53 | 738.20 | 1.99% |
| NZX 50 Index | 12,599.38 | 65.62 | -0.52% |
| S&P 500 | 5,713.64 | 95.38 | 1.70% |
| S&P/ASX 200 | 8,228.00 | 36.10 | 0.44% |
| SSE Composite Index | 2,734.23 | 1.79 | -0.07% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Core Lithium Ltd CXO | 0.10 | 0.00 | 0.00% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -7.14% |
| Tabcorp Holdings Ltd TAH | 0.45 | 0.02 | 3.49% |
| Imugene Ltd IMU | 0.05 | 0.00 | 0.00% |
| Appen Ltd APX | 1.85 | 0.06 | 3.06% |
| Pilbara Minerals Ltd PLS | 2.83 | 0.05 | -1.74% |
| Australian Vanadium Ltd AVL | 0.01 | 0.00 | -3.33% |
| Mirvac Group MGR | 2.30 | 0.02 | 0.66% |
| Ioneer Ltd INR | 0.20 | 0.02 | 9.46% |
| Zip Co Ltd ZIP | 2.71 | 0.11 | 4.23% |